These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8690871)

  • 1. [Fetal and neonatal immune thrombocytopenias].
    Neuhart D; Dreyfus M; Baldauf JJ; Maloisel F; Ritter J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):206-11. PubMed ID: 8690871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmune thrombocytopenia of the fetus and the newborn.
    Kaplan C
    Blood Rev; 2002 Mar; 16(1):69-72. PubMed ID: 11914000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal thrombocytopenia. Predicting neonatal thrombocytopenia with cordocentesis.
    Berry SM; Leonardi MR; Wolfe HM; Dombrowski MP; Lanouette JM; Cotton DB
    J Reprod Med; 1997 May; 42(5):276-80. PubMed ID: 9172117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fetal-neonatal thrombocytopenia of immunologic origin: current aspects].
    Kaplan C; Morel-Kopp MC; Forestier F; Dreyfus M; Daffos F; Tchernia G
    Pathol Biol (Paris); 1994 Oct; 42(8):783-9. PubMed ID: 7724251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura in pregnancy.
    Sainio S; Joutsi L; Järvenpää AL; Kekomäki R; Koistinen E; Riikonen S; Teramo K
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):272-7. PubMed ID: 9539271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal management of the thrombocytopenias.
    Menell JS; Bussel JB
    Clin Perinatol; 1994 Sep; 21(3):591-614. PubMed ID: 7982336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet disorders in pregnancy: implications for mother and fetus.
    Paidas MJ; Haut MJ; Lockwood CJ
    Mt Sinai J Med; 1994 Oct; 61(5):389-403. PubMed ID: 7799975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital posthemorrhagic hydrocephalus: a case of fetomaternal alloimmune thrombocytopenia.
    Póvoa AM; Ramalho C; Machado AP; Matias A; Montenegro N
    Fetal Diagn Ther; 2007; 22(5):321-4. PubMed ID: 17556816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal diagnosis and management of fetomaternal alloimmune thrombocytopenia.
    Dickinson JE; Marshall LR; Phillips JM; Barr AL
    Am J Perinatol; 1995 Sep; 12(5):333-5. PubMed ID: 8540936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune thrombocytopenia and pregnancy].
    Sandoval Rodríguez T
    Ginecol Obstet Mex; 1995 Jun; 63():246-9. PubMed ID: 7642150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy.
    Kaplan C
    Transfus Clin Biol; 2001 Jun; 8(3):311-4. PubMed ID: 11499984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura.
    Samuels P; Bussel JB; Braitman LE; Tomaski A; Druzin ML; Mennuti MT; Cines DB
    N Engl J Med; 1990 Jul; 323(4):229-35. PubMed ID: 2366833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis of fetal thrombocytopenia].
    Póka R; Katona N; Juhász B
    Orv Hetil; 1997 Feb; 138(8):485-6. PubMed ID: 9139253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
    Radder CM; Brand A; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous umbilical blood sampling in pregnant women with thrombocytopenia. Apropos of 35 cases].
    Razafintsalama T; Coiffic J; Godin O; Lassel L; Chevrant-Breton O; Poulain P
    J Gynecol Obstet Biol Reprod (Paris); 2000 Apr; 29(2):176-84. PubMed ID: 10790630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.
    Kroll H; Yates J; Santoso S
    Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal/neonatal allo-immune thrombocytopenias: the unsolved questions].
    Kaplan C
    Transfus Clin Biol; 2005 Jun; 12(2):131-4. PubMed ID: 15950890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia.
    Bertrand G; Martageix C; Jallu V; Vitry F; Kaplan C
    J Thromb Haemost; 2006 Mar; 4(3):628-37. PubMed ID: 16460445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.